Boca Biolistics

Boca Biolistics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Boca Biolistics is a specialized contract research organization (CRO) and biobank that provides critical research materials and laboratory services to the life sciences industry. Its core business revolves around procuring and storing high-quality, clinically characterized biospecimens (biofluids, tissues, PBMCs) and offering central lab testing and clinical trial management services. With a global network spanning over 50 countries and 120+ collection sites, the company positions itself as a one-stop partner to accelerate research from early discovery through product launch, particularly in areas like infectious disease, oncology, and autoimmune disorders. Its value proposition is based on reliable sourcing, rapid turnaround, and regulatory-compliant data.

CancerInfectious DiseaseSexually Transmitted InfectionsAutoimmuneGI/Microbiome

Technology Platform

Integrated service platform comprising a global biospecimen procurement network, a CAP/CLIA-certified central laboratory for clinical testing and assay validation, and a full suite of clinical trial management services.

Opportunities

Growth is fueled by increasing demand for high-quality, annotated biospecimens in precision medicine and IVD development.
The integrated model allows capture of value across the R&D continuum, from sample sourcing to clinical validation.
Expansion of its global collection network can open new geographic markets and diverse patient populations for clients.

Risk Factors

The business faces regulatory complexity in international biospecimen procurement and data privacy.
It operates in a competitive CRO/biobank market and may face pricing pressure.
Revenue could be impacted by shifts in research funding or dependency on specific disease areas like infectious disease.

Competitive Landscape

Boca Biolistics competes with large, global CROs (e.g., LabCorp, IQVIA) that offer central lab services, as well as specialized biobanks and sample procurement firms. Its differentiation lies in its focused integration of procurement and validation testing for the IVD sector, its specific disease area expertise (e.g., infectious disease), and its emphasis on partnership and customer service.